Ryan Englander

Also affiliated with The Jackson Laboratory for Genomic Medicine, UConn Health

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection”.

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection

Journal of Clinical Investigation(2020)10.1172/jci142823

N/A

0.538DataRank · unranked

35 citations

Mariam M. George, Marmar M. Moussa, Adam T. Hagymasi, Sahar Al Seesi, Tatiana Shcheglova +8 more

Intron retention regulates STAT2 function and predicts immunotherapy response in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.19.671121

N/A

0.104DataRank · unranked

1 citations

Mattia Brugiolo, Te-Chia Wu, Mitch Kostich, Nathan K. Leclair, Sung-Hee Park +7 more

CRISPR-guided reversion reveals the immunogenicity of a “non-MHC binding” cancer neoepitope in vivo

Research Square(2020)10.21203/rs.3.rs-119173/v1

N/A

0DataRank · unranked

0 citations

Marmar R. Moussa, Ryan Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak +11 more

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope

Nature Communications(2021)10.1038/s41467-021-26646-5

N/A

0DataRank · unranked

30 citations

Marmar R. Moussa, Ryan Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak +11 more